Intracellular signaling and genetic reprogramming during agonist-induced hypertrophy of cardiomyocytes.
Van Heugten
H A
HA
Department of Biochemistry, Cardiovascular Research Institute COEUR, Faculty of Medicine & Health Sciences, Erasmus University Rotterdam, The Netherlands.
De Jonge
H W
HW
Bezstarosti
K
K
Sharma
H S
HS
Verdouw
P D
PD
Lamers
J M
JM
D000316:Adrenergic alpha-Agonists / Q000494:pharmacology*; D000804:Angiotensin II / Q000494:pharmacology*; D000818:Animals; D006332:Cardiomegaly / Q000503:physiopathology*; D002455:Cell Division; D002478:Cells, Cultured; D016232:Endothelins / Q000494:pharmacology*; D006321:Heart / Q000187:drug effects / Q000502:physiology* / Q000503:physiopathology; D010716:Phosphatidylinositols / Q000378:metabolism; D018340:Receptors, Adrenergic, alpha-1 / Q000502:physiology; D015398:Signal Transduction; D013917:Thrombin / Q000494:pharmacology*
D000316:Adrenergic alpha-Agonists; D016232:Endothelins; D010716:Phosphatidylinositols; D018340:Receptors, Adrenergic, alpha-1; D000804:Angiotensin II; D013917:Thrombin